Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial-Reference-Cited by-同舟云学术

Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial

Published:2020-01-01 Issue:1 Volume:9 Page:843-850
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Chen Jun¹^ORCID,Chen Rong¹,Shen Yinzhong¹,Wei Hongxia²,Wang Xicheng³,Zhang Renfang¹,Hu Zhiliang²,Xie Ronghui³,Huang Qiong³,Wang Jiangrong¹,Liu Li¹,Qi Tangkai¹,Wang Zhenyan¹,Song Wei¹^ORCID,Tang Yang¹,Sun Jianjun¹,Lu Hongzhou¹^ORCID

Affiliation:

1. Department of Infectious Disease, Shanghai Public Health Clinical Center, Shanghai, People’s Republic of China

2. Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China

3. Yunnan AIDS Care Center (YNACC), Yunnan Provincial Infectious Disease Hospital, Kunming, People’s Republic of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1752609

Reference28 articles.

1. Bristol-Myers Squibb. Sustiva package insert [cited 2020 Mar 9]. Available from: https://packageinserts.bms.com/pi/pi_sustiva.pdf

2. Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide

3. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

4. A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

5. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV–Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial;Clinical Infectious Diseases;2024-01-17

2. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz–Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study;Open Forum Infectious Diseases;2023-11-20

3. Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial;Medicine;2022-12-02

4. Circulating (1 → 3)-β-D-Glucan as an immune activation marker decreased after ART in people living with HIV;Frontiers in Public Health;2022-09-14

5. Chinese Guidelines for the Diagnosis and Treatment of HIV/AIDS (2021 Edition);Infectious Diseases & Immunity;2022-02-23